Calendering as a direct shaping tool for the continuous production of fixed-dose combination products via co-extrusion

被引:19
|
作者
Vynckier, A-K. [1 ]
Lin, H. [2 ]
Zeitler, J. A. [2 ]
Willart, J-F. [3 ]
Bongaers, E. [4 ]
Voorspoels, J. [5 ]
Remon, J. P. [1 ]
Vervaet, C. [1 ]
机构
[1] Univ Ghent, Lab Pharmaceut Technol, B-9000 Ghent, Belgium
[2] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England
[3] Univ Lille 1, CNRS, UMR 8207, Unite Mat & Transformat, Lille, France
[4] Bruker MicroCT, Kontich, Belgium
[5] CONEXUS Pharrna, Ghent, Belgium
基金
英国工程与自然科学研究理事会;
关键词
Calendering; Co-extrusion; Continuous production; Fixed-dose combination product; Sustained release; Immediate release; MELT-EXTRUSION; MATRICES; DEVICES;
D O I
10.1016/j.ejpb.2015.07.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study calendering is used as a downstream technique to shape monolithic co-extruded fixed-dose combination products in a continuous way. Co-extrudates with a metoprolol tartrate-loaded sustained-release core and a hydrochlorothiazide-loaded immediate-release coat were produced and immediately shaped into a monolithic drug delivery system via calendering, using chilled rolls with tablet-shaped cavities. In vitro metoprolol tartrate release from the ethylcellulose core of the calendered tablets was prolonged in comparison with the sustained release of a multiparticulate dosage form, prepared manually by cutting co-extrudates into mini-matrices. Analysis of the dosage forms using X-ray micro-computed tomography only detected small differences between the pore structure of the core of the calendered tablet and the mini-matrices. Diffusion path length was shown to be the main mechanism behind the release kinetics. Terahertz pulsed imaging visualized that adhesion between the core and coat of the calendered tablet was not complete and a gradient in coat thickness (varying from 200 to 600 mu m) was observed. Modulated differential scanning calorimetry and X-ray diffraction indicated that the solid-state properties of both drugs were not affected by the calendering procedure. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 9 条
  • [1] Hot-melt co-extrusion for the production of fixed-dose combination products with a controlled release ethylcellulose matrix core
    Vynckier, A. -K.
    Dierickx, L.
    Saerens, L.
    Voorspoels, J.
    Gonnissen, Y.
    De Beer, T.
    Vervaet, C.
    Remon, J. P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 464 (1-2) : 65 - 74
  • [2] Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices
    Dierickx, L.
    Saerens, L.
    Almeida, A.
    De Beer, T.
    Remon, J. P.
    Vervaet, C.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) : 683 - 689
  • [3] Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product
    Vynckier, An-Katrien
    Voorspoels, Jody
    Remon, Jean Paul
    Vervaet, Chris
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (05) : 721 - 727
  • [4] Enteric protection of naproxen in a fixed-dose combination product produced by hot-melt co-extrusion
    Vynckier, A. -K.
    De Beer, M.
    Monteyne, T.
    Voorspoels, J.
    De Beer, T.
    Remon, J. P.
    Vervaet, C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 491 (1-2) : 243 - 249
  • [5] Pharmacokinetics of lamivudine, zidovudine, and Nevirapine administered as a fixed-dose combination formulation versus co administration, of the individual products
    Marier, J. F.
    DiMarco, M.
    Guilbaud, R.
    Dodard, C.
    Morelli, G.
    Tippabhotla, S. K.
    Singla, A. K.
    Thudi, N. R.
    Monif, T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (11): : 1381 - 1389
  • [6] The development of an inline Raman spectroscopic analysis method as a quality control tool for hot melt extruded ramipril fixed-dose combination products
    Andrews, G. P.
    Jones, D. S.
    Senta-Loys, Z.
    Almajaan, A.
    Li, S.
    Chevallier, O.
    Elliot, C.
    Healy, A. M.
    Kelleher, J. F.
    Madi, A. M.
    Gilvary, G. C.
    Tian, Y.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 566 : 476 - 487
  • [7] A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products
    Kelleher, J. F.
    Gilvary, G. C.
    Madi, A. M.
    Jones, D. S.
    Li, S.
    Tian, Y.
    Almajaan, A.
    Senta-Loys, Z.
    Andrews, G. P.
    Healy, A. M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 545 (1-2) : 183 - 196
  • [8] Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
    Ferguson, Gary T.
    Reisner, Colin
    Pearle, James
    DePetrillo, Paolo
    Maes, Andrea
    Martin, Ubaldo J.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 67 - 74
  • [9] KRONOS: 24-week study of triple fixed-dose combination budesonide/glycopyrronium/formoterol (BGF) MDI via co-suspension delivery technology vs glycopyrronium/formoterol (GFF) MDI, budesonide/formoterol (BFF) MDI and BFF inhalation powder in COPD
    Ferguson, Gary T.
    Rabe, Klaus F.
    Martinez, Fernando J.
    Fabbri, Leonardo M.
    Wang, Chen
    Ichinose, Masakazu
    Bourne, Eric
    Ballal, Shaila
    Deangelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52